Literature DB >> 10814785

Haemopoietic biglycan produced by brain cells stimulates growth of microglial cells.

A Kikuchi1, H Tomoyasu, I Kido, K Takahashi, A Tanaka, I Nonaka, N Iwakami, I Kamo.   

Abstract

We have recently found that soluble biglycan purified from rat thymic myoid cells had haemopoietic activity capable of inducing preferential growth and differentiation of monocytic lineage cells from various haemopoietic sources, including brain microglial cells. In the present study, to understand developmental mechanisms of microglial/monocytic cells in the brain, we have attempted to identify haemopoietic activity of the brain biglycan. The mRNA and the immunological epitope of biglycan were detected in the rat brain homogenates and several rat glial cell lines. Immunohistochemical study showed that several different types of brain cells produced biglycan. During development biglycan synthesis in the brain appeared to be increased. The brain haemopoietic biglycan was easily separated by DEAE-Sepharose chromatography from the macrophage colony stimulating factor (M-CSF) which was concomitantly produced from the brain cells. The brain haemopoietic biglycan, purified through immunoaffinity column, indeed stimulated growth of primarily cultured microglial cells. Taken together, these results suggest that the haemopoietic biglycan plays an important role in generating brain-specific circumstances for development of microglial/monocytic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814785     DOI: 10.1016/s0165-5728(99)00258-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.

Authors:  Kristin Moreth; Renato V Iozzo; Liliana Schaefer
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

2.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.

Authors:  Liliana Schaefer; Andrea Babelova; Eva Kiss; Heinz-J Hausser; Martina Baliova; Miroslava Krzyzankova; Gunther Marsche; Marian F Young; Daniel Mihalik; Martin Götte; Ernst Malle; Roland M Schaefer; Hermann-Josef Gröne
Journal:  J Clin Invest       Date:  2005-07-14       Impact factor: 14.808

3.  Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction.

Authors:  Liliana Schaefer; Katarina Macakova; Igor Raslik; Miroslava Micegova; Hermann-Josef Gröne; Elke Schönherr; Horst Robenek; Frank G Echtermeyer; Susanne Grässel; Peter Bruckner; Roland M Schaefer; Renato V Iozzo; Hans Kresse
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

4.  De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways.

Authors:  Jinyang Zeng-Brouwers; Janet Beckmann; Madalina-Viviana Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Matrix Biol       Date:  2013-12-18       Impact factor: 11.583

Review 5.  Biological interplay between proteoglycans and their innate immune receptors in inflammation.

Authors:  Helena Frey; Nina Schroeder; Tina Manon-Jensen; Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2013-02-21       Impact factor: 5.542

Review 6.  Biglycan: a multivalent proteoglycan providing structure and signals.

Authors:  Madalina V Nastase; Marian F Young; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2012-07-20       Impact factor: 2.479

Review 7.  Small leucine rich proteoglycans in host immunity and renal diseases.

Authors:  Wei Zou; Junhui Wan; Min Li; Juanjuan Xing; Qi Chen; Zhi Zhang; Yi Gong
Journal:  J Cell Commun Signal       Date:  2018-10-25       Impact factor: 5.908

Review 8.  Keratan sulfate, a complex glycosaminoglycan with unique functional capability.

Authors:  Bruce Caterson; James Melrose
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.